Literature DB >> 15946823

Quality control in breast cancer surgery.

N Birido1, J G Geraghty.   

Abstract

Quality assurance is the process by which quality care can be assessed. The general principles include setting a standard with the aim of achieving particular outcomes, followed by the evaluation of parameters that allow for quality assessment. Locoregional and survival outcomes are the major parameters but require years to evaluate and have other limitations. Other parameters therefore may assist in evaluation, such as the availability of the structures and processes required to achieve desired outcomes. Unlike chemotherapy and radiotherapy the quality of surgery is difficult to quantify, yet it is central to the issue of locoregional control and survival. In breast cancer surgery, quality control starts at the diagnostic service; from referral by the family practitioner to the appropriate triage of patients thereby preventing diagnostic delays. The surgical oncologist is pivotal in the multidisciplinary input necessary with both radiologists and pathologists in achieving the correct preoperative diagnoses of symptomatic and screen detected lesions as specified by many of the guidelines. Quality control of the operative surgery addresses issues such as training, volume and life audit of the surgeon. Standardisation of operative technique, pathology reporting with emphasis on specimen orientation and margins, management of the axilla and how it impacts on adjuvant treatment are other important issues. More recently, the availability of breast reconstruction services and the development of the oncoplastic surgeon is becoming an important quality issue. Finally, the quality of the follow up process provides the tools to assess the outcome of both the patient and the service.

Entities:  

Mesh:

Year:  2005        PMID: 15946823     DOI: 10.1016/j.ejso.2005.02.009

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

Review 1.  Best practice in forensic entomology--standards and guidelines.

Authors:  Jens Amendt; Carlo P Campobasso; Emmanuel Gaudry; Christian Reiter; Hélène N LeBlanc; Martin J R Hall
Journal:  Int J Legal Med       Date:  2006-04-22       Impact factor: 2.686

2.  Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum.

Authors:  Warren H Tseng; Thomas R Stevenson; Robert J Canter; Steven L Chen; Vijay P Khatri; Richard J Bold; Steve R Martinez
Journal:  Plast Reconstr Surg       Date:  2010-12       Impact factor: 4.730

Review 3.  Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review.

Authors:  Michael Retsky; Romano Demicheli; William J M Hrushesky; Patrice Forget; Marc De Kock; Isaac Gukas; Rick A Rogers; Michael Baum; Vikas Sukhatme; Jayant S Vaidya
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

4.  Classifying breast cancer surgery: a novel, complexity-based system for oncological, oncoplastic and reconstructive procedures, and proof of principle by analysis of 1225 operations in 1166 patients.

Authors:  Jürgen Hoffmann; Diethelm Wallwiener
Journal:  BMC Cancer       Date:  2009-04-08       Impact factor: 4.430

Review 5.  From radical mastectomy to breast-conserving therapy and oncoplastic breast surgery: a narrative review comparing oncological result, cosmetic outcome, quality of life, and health economy.

Authors:  Ahmad Kaviani; Nassim Sodagari; Sara Sheikhbahaei; Vahid Eslami; Nima Hafezi-Nejad; Amin Safavi; Maryam Noparast; Alfred Fitoussi
Journal:  ISRN Oncol       Date:  2013-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.